NCT00816751

Brief Summary

The aim of this study is to estimate the efficacy of intracervical versus paracervical block on pain experienced during first trimester suction curettage without the use of preoperative cervical ripening. Because of the theoretical improved reliability of stromal block, the investigators hypothesize that intracervical block would produce lower pain scores than paracervical block at the time of cervical dilation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
89

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2007

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2007

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2008

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 31, 2008

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 5, 2009

Completed
10.6 years until next milestone

Results Posted

Study results publicly available

August 13, 2019

Completed
Last Updated

August 13, 2019

Status Verified

July 1, 2019

Enrollment Period

2 months

First QC Date

December 31, 2008

Results QC Date

June 4, 2019

Last Update Submit

July 22, 2019

Conditions

Keywords

Local anesthesiaParacervicalIntracervicalAbortionPainLocal anesthesia for elective first trimester abortion

Outcome Measures

Primary Outcomes (1)

  • Pain Score, as Assessed Using a 10 cm Linear Visual Analog Scale (VAS)

    VAS on a scale of 1 to 10 with 1 being lowest pain and 10 highest amount of pain

    at completion of procedure

Secondary Outcomes (1)

  • Gestational Age at Time of Procedure

    At the time of the procedure

Study Arms (2)

1

ACTIVE COMPARATOR
Procedure: Paracervical blockDrug: Buffered Lidocaine, vasopressin, sodium bicarbonate

2

EXPERIMENTAL
Procedure: IntracervicalDrug: Buffered Lidocaine, vasopressin, sodium bicarbonate

Interventions

The paracervical block was administered using 20 ml of buffered lidocaine and a 5/8 inch, 25-gauge needle. A small amount was injected at the tenaculum site, and the remainder equally distributed around the cervicovaginal junction at 3, 5, 7, and 9 o'clock. The depth was standardized at 5/8 inch by inserting the needle to the hub.

1
IntracervicalPROCEDURE

The intracervical block was administered using 20 ml of buffered lidocaine and a 1-1/2 inch, 20 gauge needle in order to overcome the increased resistance to injection caused by the cervical stroma. A small amount was injected at the tenaculum site, and the remainder into the cervical stroma at 12, 3, 6, and 9 o'clock, at a depth of 1-1/2 inch by inserting the needle to the hub.

2

The buffered lidocaine preparation for both block techniques consisted of 50 mL of 1% lidocaine, 5 units of vasopressin, and 5 mL 8% sodium bicarbonate.

12

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women presenting for elective first trimester abortion

You may not qualify if:

  • Gestation over 12 weeks by ultrasound
  • Weight less than 98 pounds
  • Known allergy to lidocaine
  • Known nonviable pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Planned Parenthood

San Diego, California, 92101, United States

Location

MeSH Terms

Conditions

Pain

Interventions

Anesthesia, ObstetricalVasopressinsSodium Bicarbonate

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and AnalgesiaPituitary Hormones, PosteriorPituitary HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsNeuropeptidesPeptidesAmino Acids, Peptides, and ProteinsOligopeptidesNerve Tissue ProteinsProteinsBicarbonatesCarbonatesCarbonic AcidCarbon Compounds, InorganicInorganic ChemicalsSodium Compounds

Results Point of Contact

Title
Jessica M. Kingston, MD
Organization
UC San Diego Health

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

December 31, 2008

First Posted

January 5, 2009

Study Start

December 1, 2007

Primary Completion

February 1, 2008

Study Completion

February 1, 2008

Last Updated

August 13, 2019

Results First Posted

August 13, 2019

Record last verified: 2019-07

Locations